Why GLP-1s aren't lowering employers' costs
Many employer health plans do not cover GLP-1 medications for weight loss, despite some believing they could reduce overall healthcare costs. About 20% of employers do provide coverage, hoping that these medications will lead to lower medical expenses associated with obesity-related health issues. The effectiveness of GLP-1s in saving employers money in the long run remains uncertain.
- ▪The majority of employer health plans do not cover GLP-1s for weight loss.
- ▪Approximately 20% of employers believe that covering GLP-1s could help reduce their healthcare costs.
- ▪There is a belief that medications like Wegovy or Zepbound may lead to less medical care related to obesity.
Opening excerpt (first ~120 words) tap to expand
The Indicator from Planet Money NPR The Indicator from Planet Money LISTEN & FOLLOW NPR App Apple Podcasts Spotify Amazon Music iHeart Radio YouTube Music RSS link Why GLP-1s aren't lowering employers' costs May 19, 20263:00 AM ET By Julie Wernau , Wailin Wong , Cooper Katz McKim , Kate Concannon Why GLP-1s aren't lowering employers' costs Listen · 10:04 10:04 Toggle more options Download Embed Embed <iframe src="https://www.npr.org/player/embed/nx-s1-5826016/nx-s1-mx-5826016-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player"> Amanda Andrade-Rhoades/AP Newsroom The vast majority of employer health plans do not cover GLP-1s for weight loss. But roughly 20% do, many believing it will help their bottom line.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at NPR.
Discussion
0 commentsMore from NPR
